Breaking Down the Barriers: Challenges With Development and Implementation of an Industry-Sponsored Antimicrobial Stewardship Data Collection and Analysis Tool

被引：3

作者：

Hermsen, Elizabeth D. ^{[1
,2
]}

McDaneld, Patrick M. ^{[1
,3
]}

Eiland, Edward H., III ^{[4
]}

Destache, Christopher J. ^{[5
]}

Lusardi, Katherine ^{[6
]}

Estrada, Sandy J. ^{[7
]}

Mercier, Renee-Claude ^{[8
]}

DePestel, Daryl D. ^{[1
]}

Lamp, Kenneth C. ^{[1
]}

Anderson, Evette ^{[1
]}

Chung, Thomas J. ^{[1
]}

McKinnon, Peggy S. ^{[1
]}

机构：

[1] Cubist Pharmaceut, Global Med Affairs, Lexington, MA 02421 USA

[2] Univ Nebraska Med Ctr, Coll Pharm, Dept Pharm Practice, Omaha, NE USA

[3] Massachusetts Coll Pharm & Hlth Sci, Dept Pharm Practice, Worcester, MA USA

[4] Huntsville Dist Mem Hosp, Dept Pharm, Huntsville, AL USA

[5] Creighton Univ, Sch Pharm & Hlth Profess, Omaha, NE 68178 USA

[6] Univ Arkansas Med Sci, Med Ctr, Dept Pharm, Little Rock, AR 72205 USA

[7] Lee Mem Hlth Syst, Dept Pharm, Ft Myers, FL USA

[8] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA

来源：

CLINICAL INFECTIOUS DISEASES | 2014年 / 59卷

关键词：

antimicrobial stewardship; appropriate use; data collection and analysis; electronic data capture; INFECTIOUS-DISEASES SOCIETY; HEALTH-CARE EPIDEMIOLOGY; PROGRAM; AMERICA; STRATEGIES; GUIDELINES; HOSPITALS;

D O I：

10.1093/cid/ciu539

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Partnership between clinicians and the pharmaceutical industry with a focus on antimicrobial stewardship research initiatives is a necessary step toward meeting the shared goals of combating inappropriate antimicrobial use, improving patient outcomes, and minimizing resistance development. Achieving these goals requires outcomes-focused data collection and monitoring tools for antimicrobial stewardship programs (ASP) that consider real-world data about how antimicrobials are used to treat patients. Here we highlight the experiences and challenges associated with the development and implementation of an industry-sponsored electronic antimicrobial stewardship data collection and analysis tool (AS-DCAT). The benefits and risks of the industry-sponsored AS-DCAT from the perspectives of the sponsoring company and participating sites are discussed. Barriers encountered as well as general considerations and recommendations for preventing or overcoming those barriers for future studies and tool development are provided.

引用

页码：S179 / S184

页数：6